AU4686299A - Nek-related and bub1-related protein kinases - Google Patents

Nek-related and bub1-related protein kinases

Info

Publication number
AU4686299A
AU4686299A AU46862/99A AU4686299A AU4686299A AU 4686299 A AU4686299 A AU 4686299A AU 46862/99 A AU46862/99 A AU 46862/99A AU 4686299 A AU4686299 A AU 4686299A AU 4686299 A AU4686299 A AU 4686299A
Authority
AU
Australia
Prior art keywords
bub1
nek
protein kinases
related protein
kinases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46862/99A
Other languages
English (en)
Inventor
Ricardo Martinez
Gregory Plowman
Yingfang Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Original Assignee
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen LLC filed Critical Sugen LLC
Publication of AU4686299A publication Critical patent/AU4686299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU46862/99A 1998-06-16 1999-06-15 Nek-related and bub1-related protein kinases Abandoned AU4686299A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8952098P 1998-06-16 1998-06-16
US60089520 1998-06-16
US9826598P 1998-08-28 1998-08-28
US60098265 1998-08-28
PCT/US1999/013533 WO1999066051A2 (en) 1998-06-16 1999-06-15 Nek-related and bub1-related protein kinases

Publications (1)

Publication Number Publication Date
AU4686299A true AU4686299A (en) 2000-01-05

Family

ID=26780662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46862/99A Abandoned AU4686299A (en) 1998-06-16 1999-06-15 Nek-related and bub1-related protein kinases

Country Status (5)

Country Link
EP (1) EP1088079A2 (enExample)
JP (1) JP2002518016A (enExample)
AU (1) AU4686299A (enExample)
CA (1) CA2331889A1 (enExample)
WO (1) WO1999066051A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183962B1 (en) * 1998-09-09 2001-02-06 Millennium Pharmaceuticals, Inc. Protein kinase molecules and uses therefor
DE10011530A1 (de) * 2000-03-13 2001-09-27 Robert Elez Hochwirksame Antisense-Oligodesoxynucleotide gegen Polio-like Kinasel
AU2001266954A1 (en) * 2000-06-15 2001-12-24 Millennium Pharmaceuticals, Inc. 53070, a novel human protein kinase family member and uses thereof
AU2001273350A1 (en) * 2000-07-11 2002-01-21 Deltagen, Inc. Transgenic mice containing targeted kinase gene disruptions
AU2002214576A1 (en) * 2000-10-13 2002-04-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Genes related to development of refractory prostate cancer
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US20040097441A1 (en) * 2002-11-16 2004-05-20 Isis Pharmaceuticals Inc. Modulation of NIMA-related kinase 6 expression
EP1554578A2 (en) * 2002-06-11 2005-07-20 The General Hospital Corporation Identification of inhibitors of mitosis
CA2907730A1 (en) * 2013-03-21 2014-09-25 Bayer Pharma Aktiengesellschaft Diaminoheteroaryl substituted indazoles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863780A (en) * 1996-09-12 1999-01-26 Incyte Pharmaceuticals, Inc. Human Protein Kinases
AU7828698A (en) * 1997-06-11 1998-12-30 Chiron Corporation Detection of loss of the wild-type (hu)bub1 gene
AU1614099A (en) * 1997-12-01 1999-06-16 Fox Chase Cancer Center Novel genes encoding proteins involved in mitotic checkpoint control and methodsof use thereof
WO1999047638A2 (en) * 1998-03-16 1999-09-23 The Johns Hopkins University School Of Medicine Mutations in mitotic check point genes and methods of diagnosis
US5928874A (en) * 1998-03-27 1999-07-27 Incyte Pharmaceuticals, Inc. Nek1-related protein kinase
CN1158386C (zh) * 1998-04-29 2004-07-21 吉尼西斯研究及发展有限公司 从皮肤细胞中分离的多核苷酸及其使用方法
JP2002524046A (ja) * 1998-08-04 2002-08-06 イミュネックス・コーポレーション キナーゼ作用を有するポリペプチドをコードするマウスｄｎａ分子

Also Published As

Publication number Publication date
JP2002518016A (ja) 2002-06-25
CA2331889A1 (en) 1999-12-23
EP1088079A2 (en) 2001-04-04
WO1999066051A3 (en) 2000-06-15
WO1999066051A2 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
AU5173400A (en) Protein kinases
AU2434199A (en) Protein
AU9790198A (en) Compounds and methods
AU6058500A (en) Fusion protein and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU5091199A (en) Prion protein and uses thereof
AU5340399A (en) Proteases and associated proteins
AU6142899A (en) Human transferase proteins
AU4261197A (en) Human protein kinases
IL128570A0 (en) Protein kinases and uses thereof
AU4686299A (en) Nek-related and bub1-related protein kinases
AU3656497A (en) Traf2-associated protein kinase and assays
AU1914400A (en) Human hydrolase proteins
AU2591299A (en) Human protein kinase c inhibitor
AU2136401A (en) P450rai-2 and related proteins
AU1456899A (en) Human protein kinase and kinase inhibitors
AU2538899A (en) Protein kinase c
AU4992099A (en) Human presenilin-associated protein
AU2980799A (en) Lectomedin materials and methods
AU3411999A (en) Novel rnase-like protein and its use
AU2593199A (en) Human smn-like protein
AU1690200A (en) Novel protein and dna thereof
AU4438599A (en) Human arf-related proteins
ZA987206B (en) Cycline-dependent protein kinase-activating kinase and its uses
AU3097299A (en) Nek1-related protein kinase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase